A Phase IV Open-Label, Non-Randomized, Multi-Cohort, Multicenter Study in Previously Unvaccinated Immunocompromised Adults to Determine the Immunogenicity and Safety of AZD1222 Vaccine for the Prevention of COVID-19. (VICTORIA)

19/01/2022
23/04/2024
EU PAS number:
EUPAS44425
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

EUPAS44425 D8111C00010 - Protocol_18Mar2022_Redacted

English (3.01 MB - PDF) View document
Updated protocol

D8111C00010-CSP Amendment-3-v4_Redacted_PDFA

First published: 22/02/2024
English (1.43 MB - PDF) View document
Study results
Study results

D8111C00010-CSR synopsis_Redacted_PDFA

English (1.48 MB - PDF) View document
Study report
Other information